”Good Disruption” is a lively discussion between UVA Darden School of Business Professors Mike Lenox and Yael Grushka-Cockayne on cutting edge technologies and practices that are challenging the status quo.
All content for Good Disruption is the property of University of Virginia Darden School of Business and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
”Good Disruption” is a lively discussion between UVA Darden School of Business Professors Mike Lenox and Yael Grushka-Cockayne on cutting edge technologies and practices that are challenging the status quo.
Good Disruption: Episode 26 - GLP-1 Medications for Weight Loss
Good Disruption
42 minutes
1 month ago
Good Disruption: Episode 26 - GLP-1 Medications for Weight Loss
Serena Williams recently made headlines for her promotion of GLP-1 medications. The tennis super star is one of a growing list of celebrities turning to GLP-1s, drugs originally developed to treat patients with Type II diabetes and obesity, to help with weight loss.
Off-label use of these medications is rapidly expanding, disrupting a fitness industry built on helping people lose weight. In May, Weight Watchers filed for bankruptcy. Questions also loom over any long-term disruptions to the human body.
Mike and Yael talk with Dr. Sandhya Chhabra (MBA’17) about the benefits, cautions, and unknowns surrounding the drug that is making headlines and changing lives. Dr. Chhabra led an endocrinology practice for 20 years and is currently a Senior Medical Advisor for Springbok Analytics.
Good Disruption
”Good Disruption” is a lively discussion between UVA Darden School of Business Professors Mike Lenox and Yael Grushka-Cockayne on cutting edge technologies and practices that are challenging the status quo.
